Brentuximab Vedotin,Dacarbazine,Doxorubicin,Filgrastim,Nivolumab,Pegfilgrastim,vinblastine
amgen,bms,seagen
['lymphoma', 'lymsm', 'hodgkin']
great summary of three new hodgkin lymphoma trials presented at #17icml by prof dreyling - 2 new standards of care (n-avd and pet-adapted brecadd) - will be challenging to choose both for individual patients and for future trial control arms
#lymsm 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem